FRASCA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 4.292
EU - Europa 2.176
AS - Asia 1.814
SA - Sud America 289
AF - Africa 225
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AN - Antartide 1
Totale 8.809
Nazione #
US - Stati Uniti d'America 4.111
SG - Singapore 866
IT - Italia 850
CN - Cina 703
IE - Irlanda 450
UA - Ucraina 370
BR - Brasile 272
DE - Germania 169
CA - Canada 160
CI - Costa d'Avorio 158
RU - Federazione Russa 104
KR - Corea 64
IN - India 57
SE - Svezia 48
SN - Senegal 47
GB - Regno Unito 40
VN - Vietnam 29
FR - Francia 20
PL - Polonia 20
TR - Turchia 20
FI - Finlandia 19
IR - Iran 19
CH - Svizzera 18
UZ - Uzbekistan 17
CZ - Repubblica Ceca 15
MX - Messico 12
NL - Olanda 12
BE - Belgio 9
GR - Grecia 7
AU - Australia 6
BD - Bangladesh 6
ES - Italia 6
JP - Giappone 6
PY - Paraguay 6
SA - Arabia Saudita 6
EU - Europa 5
AR - Argentina 4
BG - Bulgaria 4
NG - Nigeria 4
RO - Romania 4
AT - Austria 3
AZ - Azerbaigian 3
EC - Ecuador 3
KE - Kenya 3
LB - Libano 3
LU - Lussemburgo 3
MA - Marocco 3
PK - Pakistan 3
TN - Tunisia 3
VE - Venezuela 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
HK - Hong Kong 2
JM - Giamaica 2
AL - Albania 1
AQ - Antartide 1
BB - Barbados 1
BN - Brunei Darussalam 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
MK - Macedonia 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
RS - Serbia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.809
Città #
Santa Clara 727
Singapore 546
Chandler 491
Dublin 449
Chicago 401
Jacksonville 391
Houston 238
Boardman 203
Catania 186
Hefei 168
Civitanova Marche 164
Abidjan 158
Ashburn 141
Quintano 129
Nanjing 127
Cambridge 122
Lawrence 121
Andover 119
Toronto 111
Beijing 88
Grafing 79
Wilmington 71
Seoul 63
San Mateo 62
Des Moines 59
Dakar 47
Nanchang 44
Bremen 39
Los Angeles 35
Hebei 34
Jiaxing 31
Munich 30
Saint Petersburg 29
Shenyang 29
Ottawa 28
Council Bluffs 27
Palermo 27
The Dalles 27
Columbus 25
Kochi 24
Bari 23
Changsha 23
Tianjin 22
São Paulo 21
San Francisco 19
Ardabil 16
Milan 16
Brno 13
Warsaw 13
New York 12
Pozzallo 12
Augusta 11
Dong Ket 11
Hanoi 11
Pune 11
Washington 11
Brussels 9
Leawood 9
Moscow 9
Paternò 9
Stockholm 9
Belpasso 8
Jinan 8
Lappeenranta 8
Manchester 8
Mascalucia 8
Seattle 8
Falls Church 7
Guangzhou 7
Montreal 7
Phoenix 7
Redwood City 7
Rio de Janeiro 7
Rome 7
Turku 7
Amsterdam 6
Brasília 6
Naples 6
Norwalk 6
Tashkent 6
Tokyo 6
Valledolmo 6
Vancouver 6
Ann Arbor 5
Asunción 5
Belo Horizonte 5
Brooklyn 5
Curitiba 5
Edinburgh 5
Florence 5
Ho Chi Minh City 5
Mumbai 5
Philadelphia 5
Abuja 4
Ankara 4
Assago 4
Atlanta 4
Campinas 4
Chennai 4
Dallas 4
Totale 6.410
Nome #
Peroxisomal proliferator-activated receptor-γ agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells 315
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 110
c-Abl and insulin receptor signalling 103
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 100
17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells 94
Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels 93
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 93
Different Effects of the Insulin Receptor Isoforms on 32D Cell Growth and Differentiation 92
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 91
Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway 88
Different FT3/TSH correlation in acquired and congenital hypothyroid patients reveals a different hypothalamic set-point 87
Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid 87
Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells 86
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 86
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved 84
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 84
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes 84
Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism 83
Abnormal 1-hour post-load glycemia during pregnancy impairs post-partum metabolic status: a single-center experience 82
Insulin receptor isoforms in physiology and disease: An updated view 81
Challenges in the treatment of parathyroid carcinoma: a case report 80
Curcumin, hormesis and the nervous system 79
Early detection of suspicious lymph nodes in differentiated thyroid cancer 77
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 77
Worldwide increasing incidence of thyroid cancer:update on epidemiology and risk factors 76
BRAF T1799A Mutation in Thyroid Cancer Predicts Progressive disease 76
Interleukin-4 stimulates papillary thyroid cancer cell survival: Implications in patients with thyroid cancer and concomitant Graves' disease 76
Early Massive Fibrosis of a Single Extraocular Muscle Causing Severe Unilateral Euthyroid Graves' Ophthalmopathy in a Patient with Hypercholesterolemia Who Smokes 75
Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study 75
BRAF(V600E) mutation and the biology of papillary thyroid cancer 75
ROLE OF BRAF(V600) MUTATION IN THE RESISTANCE TO GEFITINIB OF THYROID CANCER CELLS 74
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 74
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management 73
The isoform A of the insulin receptor as a regulator of the IGF system 72
p53 family proteins in thyroid cancer 71
Papillary thyroid cancer incidence in the volcanic area of Sicily 71
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 71
Surveillance of patients with differentiated thyroid cancer and indeterminate response: a longitudinal study on basal thyroglobulin trend 71
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 70
p73 tumor-suppressor activity is impaired in human thyroid cancer 70
Isolation and characteriziation of cancer thyrospheres 70
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 70
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 70
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 70
Seasonal Variations in TSH Serum Levels in Athyreotic Patients under L-Thyroxine Replacement Monotherapy. 70
Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity 70
Cytological diagnosis difficulties in hyalinizing trabecular adenoma of the thyroid 69
The p53-homologue p63 may promote thyroid cancer progression 68
Il BRAF (V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al gefinitib. 68
Thyroid Cancer and Circadian Clock Disruption 68
Updates on the management of advanced, metastatic, and radioiodine refractory differentiated thyroid cancer 67
INVOLVEMENT OF THE P53 HOMOLOGOUS P73 IN THYROID CANCER PROGRESSION 67
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 67
EXOME WIDE ANALYSIS IN 5 PAPILLARY THYROID CARCINOMAS 65
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism 65
HMGA1 inhibits the function of p53 family members in thyroid cancer cells 65
Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves' Ophthalmopathy to Parenteral Corticosteroids 65
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 64
TAp63alfa antagonizes p53 oncosuppressor function in thyroid cancer cells 64
Impact of post-operative radioiodine remnant abalation in differentiated thyroid cancer according to risk categories. 64
Le cellule staminali tiroidee, isolate da gozzi di soggetti adulti, crescono in aggregati sferici in risposta a stimolazione con fattori di crescita e necessitano del TSH per differenziare in Tireociti maturi 63
DeltaNp73alfa favors thyroid tumor progression by PTEN tumor suppressor downregulation 63
TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 63
Thyrospheres an in vitro model for human thyroid carcinogenesis 62
Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling 62
Insulin and hybrid insulin/IGF receptors are major regulators of breast cancer cells 61
Tap73alfa Increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 61
In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription 60
Obesity, insulin-resistance and cancer 60
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease 60
Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells 60
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 59
Diabetes and cancer 59
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years 59
Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression 59
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 58
The possible role of cancer stem cells in the resistance to kinase inhibitors of advanced thyroid cancer 58
Expression of neurotrophins, GDNF and their receptors in rat thyroid tissue 57
IGF and insulin receptor signaling in breast cancer 57
The role of insulin receptors and IGF-I receptors in cancer and other diseases 57
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 57
DeltaNp73alfa increases Akt phosphorylation in thyroid cancer cells: role of PTEN tumor suppressor 56
Insulin-stimulated cell growth in insulin receptor substrate-1-deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase-independent pathway 56
Insulin receptors in breast cancer 56
The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome. 55
GENOME WIDE ANALYSIS IN PAPILLARY THYROID CARCINOMA 55
Insulin-like growth factor II stimulates cell growth through the insulin receptor in brest cancer: a newly identified autocrine/paracrine loop 55
Sintesi del mechano growth factor (MGF) umano ricombinante nell’Escherichia coli 55
Effect of gluten-free diet on autoimmune thyroiditis progression in patients with no symptoms or histology of celiac disease: a meta-analysis 54
The insulin receptor isoform-A is a high affinity IGF-II receptor in human fetal cells 54
Re:Insulin, Insulin-like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women 54
The role of insulin receptor isoform a (IR-A) in cancer 54
Nuove strategie di indagine delle linfoadenopatie nel carcinoma tiroideo 53
Registro tumori tiroidei di Sicilia: studi di epidemiologia molecolare 53
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes. 53
Role of c-Abl tyrosine Kinase in Insulin and IGF-I signaling 52
Thyroid cancer cell resistance to gefinitib depends on the constitutive oncogenic activation of the ERK pahway 52
Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity 51
Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients 51
The expression of PTEN tumor suppressor is down regulated by the dominant negative p73 isoform ΔNp73 in thyroid cancer cells 50
Totale 7.126
Categoria #
all - tutte 33.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021742 0 59 82 2 186 22 87 14 135 4 127 24
2021/2022879 107 128 6 11 127 9 134 34 81 3 27 212
2022/20231.700 129 46 31 316 150 278 2 264 388 21 46 29
2023/2024829 40 128 33 58 41 153 41 63 6 20 111 135
2024/20253.135 40 615 154 266 629 336 60 93 190 273 237 242
2025/2026579 403 176 0 0 0 0 0 0 0 0 0 0
Totale 9.041